Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2015 (2015), Article ID 192724, 8 pages
http://dx.doi.org/10.1155/2015/192724
Research Article

Influence of Moxifloxacin on Hepatic Redox Status and Plasma Biomarkers of Hepatotoxicity and Nephrotoxicity in Rat

Biochemistry Unit, Department of Chemical Sciences, Ajayi Crowther University, PMB 1066, Oyo 211213, Oyo State, Nigeria

Received 31 July 2015; Accepted 20 September 2015

Academic Editor: Andrei Surguchov

Copyright © 2015 Ayokanmi Ore and Ebenezer Tunde Olayinka. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Tulkens, P. Arvis, and F. Kruesmann, “Moxifloxacin safety: an analysis of 14 years of clinical data,” Drugs in R & D, vol. 12, no. 2, pp. 71–100, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. P. M. Dandagi, A. M. Belekar, V. S. Mastiholimath, A. P. Gadad, V. W. Sontake, and P. S. Salian, “An improvement of the efficacy of moxifloxacin HCl for the treatment of bacterial keratitis by the formulation of ocular mucoadhesive microspheres,” Scientia Pharmaceutica, vol. 81, no. 1, pp. 259–280, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Kuzman, A. Bezlepko, I. K. Topuzovska et al., “Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI),” BMC Pulmonary Medicine, vol. 14, article 105, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. Bayer Inc, “Moxifloxacin hydrochloride tablets,” in AVELOX Product Monograph, Bayer Inc, Ontario, Canada, 2012. View at Google Scholar
  5. P. A. Moise, M. C. Birmingham, and J. J. Schentag, “Pharmacokinetics and metabolism of moxifloxacin,” Drugs of Today, vol. 36, no. 4, pp. 229–244, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. L. D. Saravolatz and J. Leggett, “Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones,” Clinical Infectious Diseases, vol. 37, no. 9, pp. 1210–1215, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. D. N. Fish, “Fluoroquinolone adverse effects and drug interactions,” Pharmacotherapy, vol. 21, no. 10, pp. 253S–272S, 2001. View at Google Scholar · View at Scopus
  8. A. Gürbay, B. Gonthier, D. Daveloose, A. Favier, and F. Hincal, “Microsomal metabolism of ciprofloxacin generates free radicals,” Free Radical Biology and Medicine, vol. 30, no. 10, pp. 1118–1121, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Kubo, T. Matsumoto, K. Takahashi et al., “Enhanced chemiluminescence response of polymorphonuclear leukocytes by new quinolone antimicrobials,” Chemotherapy, vol. 40, no. 5, pp. 333–336, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Matsumoto, K. Takahashi, T. Nagafuji et al., “Fleroxacin enhancement of superoxide production by polymorphonuclear leukocytes: the role of protein kinases,” Chemotherapy, vol. 42, no. 4, pp. 280–285, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Thuong-Guyot, O. Domarle, J.-J. Pocidalo, and G. Hayem, “Effects of fluoroquinolones on cultured articular chondrocytes flow cytometric analysis of free radical production,” Journal of Pharmacology and Experimental Therapeutics, vol. 271, no. 3, pp. 1544–1549, 1994. View at Google Scholar · View at Scopus
  12. V. Sureshkumar, G. Sarathchandra, and J. Ramesh, “Biochemical, histopathological and ultra structural profile after pulsed water medication of enrofloxacin in broiler chickens,” Veterinary World, vol. 6, no. 9, pp. 668–673, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. U. Schmidt and G. Schlüter, “Studies on the mechanism of phototoxicity of Bay y 3118 and other quinolones,” in Biological Reactive Intermediates V: Basic Mechanistic Research in Toxicology and Human Risk Assessment, vol. 387 of Advances in Experimental Medicine and Biology, pp. 117–120, Springer, Berlin, Germany, 1996. View at Publisher · View at Google Scholar
  14. E. Yazar and B. Tras, “Effects of fluoroquinolone antibiotics on hepatic superoxide dismutase and glutathione peroxidase activities in healthy and experimentally induced peritonitis mice,” Revue de Médecine Vétérinaire, vol. 152, no. 3, pp. 235–238, 2001. View at Google Scholar · View at Scopus
  15. M. Kavutcu, O. Canbolat, S. Öztürk et al., “Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: effects of vitamins E and C,” Nephron, vol. 72, no. 2, pp. 269–274, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Rahman, “Studies on free radicals, antioxidants, and co-factors,” Clinical Interventions in Aging, vol. 2, no. 2, pp. 219–236, 2007. View at Google Scholar · View at Scopus
  17. I. Albesa, M. C. Becerra, P. C. Battán, and P. L. Páez, “Oxidative stress involved in the antibacterial action of different antibiotics,” Biochemical and Biophysical Research Communications, vol. 317, no. 2, pp. 605–609, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. D. J. Dwyer, M. A. Kohanski, B. Hayete, and J. J. Collins, “Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli,” Molecular Systems Biology, vol. 3, article 91, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. F. A. D. T. G. Wagener, C. E. Carels, and D. M. S. Lundvig, “Targeting the redox balance in inflammatory skin conditions,” International Journal of Molecular Sciences, vol. 14, no. 5, pp. 9126–9167, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Wang, X. Zhao, M. Malik, and K. Drlica, “Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 3, pp. 520–524, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Ø. Jensen, A. Briales, R. P. Brochmann et al., “Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms,” Pathogens and Disease, vol. 70, no. 3, pp. 440–443, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. National Research Council, Guide for the Care and Use of Laboratory Animals, The National Academies Press, National Research Council, Washington, DC, USA, 8th edition, 2011.
  23. A. G. Gornall, C. J. Bardwawill, and M. M. David, “Determination of serum proteins by means of the biuret reaction,” The Journal of Biological Chemistry, vol. 177, no. 2, pp. 751–766, 1949. View at Google Scholar · View at Scopus
  24. E. R. Jaffé, “Oxidative hemolysis, or what made the red cell break?” The New England Journal of Medicine, vol. 286, no. 3, pp. 156–157, 1972. View at Publisher · View at Google Scholar · View at Scopus
  25. N. W. Tietz, Clinical Guide to Laboratory Tests, W.B. Saunders, Philadelphia, Pa, USA, 3rd edition, 1995.
  26. N. W. Tietz, E. L. Pruden, and O. Siggaard-Andersen, “Electrolytes,” in Tietz Textbook of Clinical Chemistry, C. A. Burtis and E. R. Ashwell, Eds., pp. 1354–1374, WB Saunders, London, UK, 1994. View at Google Scholar
  27. S. Reltman and S. A. Frankel, “Colorimetric method for the determination of serum ALT and AST,” American Journal of Clinical Pathology, vol. 28, pp. 56–63, 1957. View at Google Scholar
  28. P. Trinder, “Enzymatic colorimetric method of cholesterol determination,” Annals of Clinical Biochemistry, vol. 6, article 24, 1969. View at Google Scholar
  29. D. J. Jollow, J. R. Mitchell, N. Zampaglione, and J. R. Gillette, “Bromobenzene induced liver necrosis, protective role of glutathione and evidence for 3,4 bromobenzene oxide as the hepatotoxic metabolite,” Pharmacology, vol. 11, no. 3, pp. 151–169, 1974. View at Publisher · View at Google Scholar · View at Scopus
  30. S. K. Jagota and H. M. Dani, “A new colorimetric technique for the estimation of vitamin C using Folin phenol reagent,” Analytical Biochemistry, vol. 127, no. 1, pp. 178–182, 1982. View at Publisher · View at Google Scholar · View at Scopus
  31. W. H. Habig, M. J. Pabst, and W. B. Jakoby, “Glutathione S-transferases. The first enzymatic step in mercapturic acid formation,” Journal of Biological Chemistry, vol. 249, no. 22, pp. 7130–7139, 1974. View at Google Scholar · View at Scopus
  32. H. P. Misra and I. Fridovich, “The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide dismutase,” The Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170–3175, 1972. View at Google Scholar · View at Scopus
  33. A. K. Sinha, “Colorimetric assay of catalase,” Analytical Biochemistry, vol. 47, no. 2, pp. 389–394, 1972. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Varshney and R. K. Kale, “Effects of calmodulin antagonists on radiation-induced lipid peroxidation in microsomes,” International Journal of Radiation Biology, vol. 58, no. 5, pp. 733–743, 1990. View at Publisher · View at Google Scholar · View at Scopus
  35. J.-P. Caeiro and P. B. Iannini, “Moxifloxacin (Avelox): a novel fluoroquinolone with a broad spectrum of activity,” Expert Review of Anti-Infective Therapy, vol. 1, no. 3, pp. 363–370, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. M. A. Ferguson and S. S. Waikar, “Established and emerging markers of kidney function,” Clinical Chemistry, vol. 58, no. 4, pp. 680–689, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Simsek, V. Tugcu, and A. I. Tasci, “New biomarkers for the quick detection of acute kidney injury,” ISRN Nephrology, vol. 2013, Article ID 394582, 9 pages, 2013. View at Publisher · View at Google Scholar
  38. S. Gowda, P. B. Desai, S. S. Kulkarni, V. V. Hull, A. A. K. Math, and S. N. Vernekar, “Markers of renal function tests,” North American Journal of Medical Sciences, vol. 2, no. 4, pp. 170–173, 2010. View at Google Scholar
  39. A. Akcay, K. Turkmen, D. Lee, and C. L. Edelstein, “Update on the diagnosis and management of acute kidney injury,” International Journal of Nephrology and Renovascular Disease, vol. 3, pp. 129–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Olayinka, A. Ore, and O. Adeyemo, “Alterations in biochemical indices and antioxidant status in rats following treatment with gatifloxacin,” British Journal of Pharmaceutical Research, vol. 6, no. 5, pp. 293–305, 2015. View at Publisher · View at Google Scholar
  41. A. Singh, T. K. Bhat, and O. P. Sharma, “Clinical biochemistry of hepatotoxicity,” Journal of Clinical Toxicology, S4, article 1, 2011. View at Publisher · View at Google Scholar
  42. I. M. Fatai, N. O. A. Imaga, and G. O. Gbenle, “Biochemical investigations into the effects of co-administration of ciprofloxacin and nicosan,” African Journal of Pharmacy and Pharmacology, vol. 7, no. 39, pp. 2674–2679, 2013. View at Publisher · View at Google Scholar
  43. D. E. Amacher, “Serum transaminase elevations as indicators of hepatic injury following the administration of drugs,” Regulatory Toxicology and Pharmacology, vol. 27, no. 2, pp. 119–130, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. E. T. Olayinka and A. Ore, “Administration of clarithromycin (Claricin) induces changes in antioxidant status and biochemical indices in rats,” Research Journal of Pharmacology, vol. 6, no. 4, pp. 52–61, 2012. View at Google Scholar · View at Scopus
  45. E. T. Olayinka, A. Ore, and O. S. Ola, “Influence of different doses of levofloxacin on antioxidant defense systems and markers of renal and hepatic dysfunctions in rats,” Advances in Toxicology, vol. 2015, Article ID 385023, 7 pages, 2015. View at Publisher · View at Google Scholar
  46. T. P. A. Devasagayam, J. C. Tilak, K. K. Boloor, K. S. Sane, S. S. Ghaskadbi, and R. D. Lele, “Free radicals and antioxidants in human health: current status and future prospects,” Journal of Association of Physicians of India, vol. 52, pp. 794–804, 2004. View at Google Scholar · View at Scopus
  47. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” The International Journal of Biochemistry & Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Halliwell, “Free radicals and other reactive species in disease,” in Encyclopedia of Life Sciences, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  49. A. Pastore, G. Federici, E. Bertini, and F. Piemonte, “Analysis of glutathione: implication in redox and detoxification,” Clinica Chimica Acta, vol. 333, no. 1-2, pp. 19–39, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. M. A. Kohanski, D. J. Dwyer, B. Hayete, C. A. Lawrence, and J. J. Collins, “A common mechanism of cellular death induced by bactericidal antibiotics,” Cell, vol. 130, no. 5, pp. 797–810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. M. A. Kohanski, D. J. Dwyer, and J. J. Collins, “How antibiotics kill bacteria: from targets to networks,” Nature Reviews Microbiology, vol. 8, no. 6, pp. 423–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. V. Sureshkumar, G. Sarathchandra, and J. Ramesh, “Veterinary pharmacovigilance evaluation on impact of enrofloxacin administration on antioxidant status in broiler chicken,” International Journal of Current Microbiology and Applied Sciences, vol. 2, no. 5, pp. 335–341, 2013. View at Google Scholar
  53. A. Meister, “Glutathione-ascorbic acid antioxidant system in animals,” The Journal of Biological Chemistry, vol. 269, no. 13, pp. 9397–9400, 1994. View at Google Scholar · View at Scopus
  54. G. H. Tomkin and D. Owens, “LDL as a cause of atherosclerosis,” The Open Atherosclerosis & Thrombosis Journal, vol. 5, no. 1, pp. 13–21, 2012. View at Publisher · View at Google Scholar
  55. A. V. Khera, M. Cuchel, M. de la Llera-Moya et al., “Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis,” The New England Journal of Medicine, vol. 364, no. 2, pp. 127–135, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. B.-L. Yu, S.-P. Zhao, and X.-S. Huang, “Oxidized low-density lipoprotein: a double-edged sword on atherosclerosis,” Medical Hypotheses, vol. 69, no. 3, pp. 553–556, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. C. M. Spickett, I. Wiswedel, W. Siems, K. Zarkovic, and N. Zarkovic, “Advances in methods for the determination of biologically relevant lipid peroxidation products,” Free Radical Research, vol. 44, no. 10, pp. 1172–1202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. K. S. Montine, J. F. Quinn, T. J. Montine, V. Talla, and P. R. Veerareddy, “Overview: membrane lipid peroxidation,” in Membrane Lipid Signaling in Aging and Age-Related Disease, vol. 12 of Advances in Cell Aging and Gastrontology, pp. 11–26, Elsevier Science & Technology, 2003. View at Publisher · View at Google Scholar
  59. S. M. Rawi, I. M. Mourad, N. M. S. Arafa, and N. I. Alazabi, “Effect of ciprofloxacin and levofloxacin on some oxidative stress parameters in brain regions of male albino rats,” African Journal of Pharmacy and Pharmacology, vol. 5, no. 16, pp. 1888–1897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. O. Ioannidis, B. Papaziogas, P. Tsiaousis, G. Paraskevas, E. J. Giamarellos-Bourboulis, and I. Koutelidakis, “Effect of moxifloxacin on survival, lipid peroxidation and inflammation in immunosuppressed rats with soft tissue infection caused by Stenotrophomonas maltophilia,” Microbiology and Immunology, vol. 58, no. 2, pp. 96–102, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. E. T. Olayinka and A. Ore, “Influence of Azithromycin treatment on hepatic lipid peroxidation and antioxidant defence systems of rats,” British Journal of Pharmaceutical Research, vol. 4, no. 2, pp. 240–256, 2014. View at Publisher · View at Google Scholar
  62. V. Talla and P. R. Veerareddy, “Oxidative stress induced by fluoroquinolones on treatment for complicated urinary tract infections in Indian patients,” Journal of Young Pharmacists, vol. 3, no. 4, pp. 304–309, 2011. View at Publisher · View at Google Scholar · View at Scopus